(Q35127913)
Statements
Derivation of an in vivo drug exposure breakpoint for flucytosine against Candida albicans and Impact of the MIC, growth rate, and resistance genotype on the antifungal effect (English)
Thomas J Walsh
George L Drusano
Peter A Warn
Andrew Sharp
5 September 2006
1 reference